Cytokinetics (NASDAQ:CYTK) EVP Fady Ibraham Malik Sells 2,000 Shares
MarketBeat
Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Fady Ibraham Malik sold 2,000 shares of the company's stock in a transaction that occurred on Tuesday, October 7th. The stock was sold at an average price of $60.56, for a total transaction of $121,120.00. Following the completion of the transaction, the executive vice president owned 140,610 shares in the company, valued at approximately $8,515,341.60. This represents a 1.40% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
NASDAQ:CYTK